{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T16:16:07Z","timestamp":1782836167026,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001872","name":"Centro para el Desarrollo Tecnol\u00f3gico Industrial","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001872","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Probelte Pharma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-08875-x","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T10:58:36Z","timestamp":1748429916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of a house dust mites allergoid in patients with allergic rhinitis\u2014PROACAROS study: protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Inmaculada","family":"Buend\u00eda-Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Matas-Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Garriga-Baraut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Roger-Reig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Tabar-Purroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the PROACAROS investigator group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Burch\u00e9s Baixauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Cardona Dalh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Vicente","family":"Castell\u00f3 Carrascosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"D\u00edaz Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Dordal Culla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"El-Qutob L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Ferrer Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Hermida Clarena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Pilar","family":"Lara de la Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mart\u00ednez Lezcano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"P\u00e9rez Formoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Torres Ja\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Tortajada Girb\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"3","key":"8875_CR1","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/all.13066","volume":"72","author":"MA Calderon","year":"2017","unstructured":"Calderon MA, Vidal C, Rodriguez Del Rio P, Just J, Pfaar O, Tabar AI, et al. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment. Allergy. 2017;72(3):462\u201372.","journal-title":"Allergy"},{"issue":"3","key":"8875_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jaci.2015.04.047","volume":"136","author":"M Jutel","year":"2015","unstructured":"Jutel M, Agache I, Bonini S, Burks AW, Calderon M, Canonica W, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol. 2015;136(3):556\u201368.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8875_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2165\/00002018-199410010-00002","volume":"10","author":"J Bousquet","year":"1994","unstructured":"Bousquet J, Michel FB. Safety considerations in assessing the role of immunotherapy in allergic disorders. Drug Saf. 1994;10(1):5\u201317.","journal-title":"Drug Saf"},{"issue":"2 Pt 2","key":"8875_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0091-6749(85)90661-X","volume":"76","author":"LC Grammer","year":"1985","unstructured":"Grammer LC, Shaughnessy MA, Patterson R. Modified forms of allergen immunotherapy. J Allergy Clin Immunol. 1985;76(2 Pt 2):397\u2013401.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"8875_CR5","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1111\/j.1398-9995.2010.02413.x","volume":"65","author":"O Pfaar","year":"2010","unstructured":"Pfaar O, Robinson DS, Sager A, Emuzyte R. Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysis. Allergy. 2010;65(12):1614\u201321.","journal-title":"Allergy"},{"issue":"3","key":"8875_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2500\/aap.2007.28.2996","volume":"28","author":"WL Smits","year":"2007","unstructured":"Smits WL, Giese JK, Letz KL, Inglefield JT, Schlie AR. Safety of rush immunotherapy using a modified schedule: a cumulative experience of 893 patients receiving multiple aeroallergens. Allergy Asthma Proc. 2007;28(3):305\u201312.","journal-title":"Allergy Asthma Proc"},{"key":"8875_CR7","doi-asserted-by":"crossref","unstructured":"Pe\u00f1alver M. Seguridad y tolerancia de una nueva pauta r\u00e1pida. J Investig Allergol Clin Immunol. 2016;26 Suppl 1(Suppl 1):271.","DOI":"10.18176\/jiaci.0070"},{"issue":"Suppl 2","key":"8875_CR8","first-page":"39","volume":"10","author":"M Pe\u00f1alver","year":"2017","unstructured":"Pe\u00f1alver M, Mart\u00ednez P, Lluch M, Malet A. Efficacy and safety of Beltavac Polimerizado in children between 3 and 12 - Poster A22. World Allergy Organ J. 2017;10(Suppl 2):39.","journal-title":"World Allergy Organ J"},{"key":"8875_CR9","first-page":"207","volume":"3","author":"M Pe\u00f1alver","year":"2015","unstructured":"Pe\u00f1alver M, Sanz J, Sancha JE, Vila B, Cerezo A, Mart\u00ednez A. Estudio retrospectivo de seguridad de Beltavac(R) polimerizado administrado en ni\u00f1os mediante pauta agrupada-rush. Allergol Immunopathol Proc. 2015;3:207\u20138.","journal-title":"Allergol Immunopathol Proc"},{"issue":"11","key":"8875_CR10","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/all.13201","volume":"72","author":"S Dhami","year":"2017","unstructured":"Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis. Allergy. 2017;72(11):1597\u2013631.","journal-title":"Allergy"},{"key":"8875_CR11","doi-asserted-by":"crossref","unstructured":"Pfaar O, Demoly P, Gerth van Wijk R, Bonini S, Bousquet J, Canonica GW, et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy. 2014;69(7):854\u201367.","DOI":"10.1111\/all.12383"},{"issue":"Suppl 86","key":"8875_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","volume":"63","author":"J Bousquet","year":"2008","unstructured":"Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(Suppl 86):8\u2013160.","journal-title":"Allergy"},{"key":"8875_CR13","doi-asserted-by":"crossref","unstructured":"Plaza V, Blanco M, Garcia G, Korta J, Molina J, Quirce S, et al. Highlights of the Spanish Asthma Guidelines (GEMA), version 5.0. Arch Bronconeumol (Engl Ed). 2021;57(1):11\u20132.","DOI":"10.1016\/j.arbr.2020.10.010"},{"issue":"1","key":"8875_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/2045-7022-3-42","volume":"3","author":"A Narkus","year":"2013","unstructured":"Narkus A, Lehnigk U, Haefner D, Klinger R, Pfaar O, Worm M. The placebo effect in allergen-specific immunotherapy trials. Clin Transl Allergy. 2013;3(1):42.","journal-title":"Clin Transl Allergy"},{"key":"8875_CR15","unstructured":"European Medicines Agency. Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases-CHMP\/EWP\/18504\/2006. 2006."},{"issue":"2","key":"8875_CR16","first-page":"108","volume":"8","author":"SK Wise","year":"2018","unstructured":"Wise SK, Lin SY, Toskala E, Orlandi RR, Akdis CA, Alt JA, et al. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108\u2013352.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"8875_CR17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/lary.24295","volume":"124","author":"N Erekosima","year":"2014","unstructured":"Erekosima N, Suarez-Cuervo C, Ramanathan M, Kim JM, Chelladurai Y, Segal JB, et al. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review. Laryngoscope. 2014;124(3):616\u201327.","journal-title":"Laryngoscope"},{"issue":"6","key":"8875_CR18","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.jaci.2009.02.033","volume":"123","author":"PJ Bousquet","year":"2009","unstructured":"Bousquet PJ, Combescure C, Klossek JM, Daures JP, Bousquet J. Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. J Allergy Clin Immunol. 2009;123(6):1349\u201354.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8875_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2165\/11318410-000000000-00000","volume":"3","author":"RA Nathan","year":"2010","unstructured":"Nathan RA, Dalal AA, Stanford RH, Meltzer EO, Schatz M, Derebery J, et al. Qualitative Development of the Rhinitis Control Assessment Test (RCAT), an Instrument for Evaluating Rhinitis Symptom Control. Patient. 2010;3(2):91\u20139.","journal-title":"Patient"},{"issue":"1","key":"8875_CR20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1046\/j.1365-2222.2000.00668.x","volume":"30","author":"EF Juniper","year":"2000","unstructured":"Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy. 2000;30(1):132\u201340.","journal-title":"Clin Exp Allergy"},{"key":"8875_CR21","doi-asserted-by":"crossref","unstructured":"Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J Allergy Clin Immunol. 2010;125(3):569\u201374, 74 e1\u201374 e7.","DOI":"10.1016\/j.jaci.2009.10.060"},{"issue":"10","key":"8875_CR22","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/02770900701752615","volume":"44","author":"JM Vega","year":"2007","unstructured":"Vega JM, Badia X, Badiola C, Lopez-Vina A, Olaguibel JM, Picado C, et al. Validation of the Spanish version of the Asthma Control Test (ACT). J Asthma. 2007;44(10):867\u201372.","journal-title":"J Asthma"},{"key":"8875_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13601-017-0180-9","volume":"7","author":"A Bozek","year":"2017","unstructured":"Bozek A, Kolodziejczyk K, Kozlowska R, Canonica GW. Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial. Clin Transl Allergy. 2017;7:43.","journal-title":"Clin Transl Allergy"},{"issue":"929","key":"8875_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/pmj.79.929.147","volume":"79","author":"DP Kernick","year":"2003","unstructured":"Kernick DP. Introduction to health economics for the medical practitioner. Postgrad Med J. 2003;79(929):147\u201350.","journal-title":"Postgrad Med J"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08875-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-08875-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08875-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T10:58:39Z","timestamp":1748429919000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-08875-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8875"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-08875-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"24 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The IRB of the Virgen de la Arrixaca Universitary hospital acted as the trial\u2019s coordinating ethics committee. The study protocol, version 1.1, was approved on September 7\u2009th, 2021.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"All authors have read and approved this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"Inmaculada Buendia-Jimenez and Maria Matas-Ros are employees at Probelte Pharma. Teresa Garriga-Baraut, Albert Roger-Reig and Ana Tabar-Purroy have received honoraria for consulting in allergy research from Probelte Pharma.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"176"}}